Quick Answer
ONCOLYTICS BIOTECH INC reported Stockholders Equity of -$3.80 million for fiscal year 2025.
ONCOLYTICS BIOTECH INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$3.80M | -215.2% |
| 2024 | $3.30M | -83.2% |
| 2023 | $19.60M | — |
- ONCOLYTICS BIOTECH INC showed a decrease of -215.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, ONCOLYTICS BIOTECH INC’s stockholders equity has declined by 119.4% (from $19.60 million to -$3.80 million).
- The most recent figure is from ONCOLYTICS BIOTECH INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: